Michael E. Carney

39.2k total citations
41 papers, 1.6k citations indexed

About

Michael E. Carney is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Oncology. According to data from OpenAlex, Michael E. Carney has authored 41 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Reproductive Medicine, 16 papers in Obstetrics and Gynecology and 11 papers in Oncology. Recurrent topics in Michael E. Carney's work include Ovarian cancer diagnosis and treatment (23 papers), Endometrial and Cervical Cancer Treatments (14 papers) and BRCA gene mutations in cancer (4 papers). Michael E. Carney is often cited by papers focused on Ovarian cancer diagnosis and treatment (23 papers), Endometrial and Cervical Cancer Treatments (14 papers) and BRCA gene mutations in cancer (4 papers). Michael E. Carney collaborates with scholars based in United States, Japan and Ireland. Michael E. Carney's co-authors include Lynda Bergsma, Andrew Berchuck, Johnathan M. Lancaster, Charles L. Wiggins, Clyde D. Ford, Alexander Tsodikov, Robert E. Bristow, Diane C. Bodurka, Deborah Schrag and Marie Topor and has published in prestigious journals such as Journal of Clinical Oncology, JNCI Journal of the National Cancer Institute and Cancer.

In The Last Decade

Michael E. Carney

39 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael E. Carney United States 18 928 549 392 388 191 41 1.6k
Mitchell I. Edelson United States 17 788 0.8× 440 0.8× 450 1.1× 392 1.0× 408 2.1× 42 1.8k
Michael Fung‐Kee‐Fung Canada 24 849 0.9× 818 1.5× 395 1.0× 488 1.3× 179 0.9× 76 1.9k
Christopher P. DeSimone United States 22 1.0k 1.1× 587 1.1× 314 0.8× 345 0.9× 333 1.7× 53 1.7k
Deborah E. Powell United States 26 907 1.0× 651 1.2× 310 0.8× 313 0.8× 313 1.6× 81 2.0k
Eloise Chapman‐Davis United States 22 482 0.5× 383 0.7× 549 1.4× 220 0.6× 222 1.2× 95 1.6k
Patrick Imesch Switzerland 25 912 1.0× 632 1.2× 312 0.8× 158 0.4× 478 2.5× 68 1.7k
Tom Ehlen Canada 11 1.8k 2.0× 904 1.6× 448 1.1× 1.2k 3.0× 176 0.9× 15 2.3k
Katina Robison United States 18 452 0.5× 351 0.6× 192 0.5× 266 0.7× 129 0.7× 75 1.1k
Giuseppe Gullo Italy 29 888 1.0× 620 1.1× 275 0.7× 183 0.5× 192 1.0× 135 1.9k
Faina Linkov United States 24 408 0.4× 639 1.2× 569 1.5× 186 0.5× 364 1.9× 99 1.9k

Countries citing papers authored by Michael E. Carney

Since Specialization
Citations

This map shows the geographic impact of Michael E. Carney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael E. Carney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael E. Carney more than expected).

Fields of papers citing papers by Michael E. Carney

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael E. Carney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael E. Carney. The network helps show where Michael E. Carney may publish in the future.

Co-authorship network of co-authors of Michael E. Carney

This figure shows the co-authorship network connecting the top 25 collaborators of Michael E. Carney. A scholar is included among the top collaborators of Michael E. Carney based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael E. Carney. Michael E. Carney is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Wong, Jennifer, et al.. (2020). A fight-and-flight for life: A rare case of advanced cervical cancer in pregnancy. Gynecologic Oncology Reports. 32. 100565–100565.
3.
Wong, Jennifer, Jeffrey Killeen, & Michael E. Carney. (2019). Completeness of salpingectomy intended for ovarian cancer risk reduction. Gynecologic Oncology. 155(2). 280–282. 3 indexed citations
4.
Clinton, Lani, et al.. (2017). Low-Volume Lymph Node Metastases in Endometrial Carcinoma. International Journal of Gynecological Cancer. 27(6). 1165–1170. 15 indexed citations
5.
Terada, Keith Y., Michael E. Carney, Robert Kim, Hyeong Jun Ahn, & Jill Miyamura. (2016). Health Disparities in Native Hawaiians and Other Pacific Islanders Following Hysterectomy for Endometrial Cancer.. PubMed. 75(5). 137–9. 2 indexed citations
6.
Lurie, Galina, Lynne R. Wilkens, Pamela J. Thompson, et al.. (2010). Symptom presentation in invasive ovarian carcinoma by tumor histological type and grade in a multiethnic population: A case analysis. Gynecologic Oncology. 119(2). 278–284. 20 indexed citations
7.
Sueblinvong, Thanasak & Michael E. Carney. (2009). Current Understanding of Risk Factors for Ovarian Cancer. Current Treatment Options in Oncology. 10(1-2). 67–81. 56 indexed citations
8.
Lurie, Galina, Pamela J. Thompson, Katharine McDuffie, Michael E. Carney, & Marc T. Goodman. (2009). Prediagnostic symptoms of ovarian carcinoma: A case-control study. Gynecologic Oncology. 114(2). 231–236. 29 indexed citations
9.
Lurie, Galina, Lynne R. Wilkens, Pamela J. Thompson, et al.. (2008). Combined Oral Contraceptive Use and Epithelial Ovarian Cancer Risk. Epidemiology. 19(2). 237–243. 37 indexed citations
10.
Secord, Angeles Alvarez, Laura J. Havrilesky, Michael E. Carney, et al.. (2007). Weekly low-dose paclitaxel and carboplatin in the treatment of advanced or recurrent cervical and endometrial cancer. International Journal of Clinical Oncology. 12(1). 31–36. 24 indexed citations
11.
Carney, Michael E., et al.. (2007). Ovarian Cancer Hormonal and Environmental Risk Effect. Obstetrics and Gynecology Clinics of North America. 34(4). 687–700. 28 indexed citations
12.
Earle, Craig C., Deborah Schrag, Bridget A. Neville, et al.. (2006). Effect of Surgeon Specialty on Processes of Care and Outcomes for Ovarian Cancer Patients. JNCI Journal of the National Cancer Institute. 98(3). 172–180. 326 indexed citations
13.
Ferrell, Robert E., Katharine McDuffie, Keith Y. Terada, et al.. (2004). Polymorphisms of interleukin (IL)-1α, IL-1β, IL-6, IL-10, and IL-18 and the risk of ovarian cancer. Gynecologic Oncology. 95(3). 672–679. 66 indexed citations
14.
Goodman, Marc T., Catherine N. Correa, Ko‐Hui Tung, et al.. (2003). Stage at diagnosis of ovarian cancer in the United States, 1992-1997. Cancer. 97(S10). 2648–2659. 46 indexed citations
15.
Carney, Michael E., Johnathan M. Lancaster, Clyde D. Ford, Alexander Tsodikov, & Charles L. Wiggins. (2002). A Population-Based Study of Patterns of Care for Ovarian Cancer: Who Is Seen by a Gynecologic Oncologist and Who Is Not?. Gynecologic Oncology. 84(1). 36–42. 167 indexed citations
16.
Havrilesky, Laura J., Angeles A. Alvarez, Robyn Sayer, et al.. (2002). Weekly Low-Dose Carboplatin and Paclitaxel in the Treatment of Recurrent Ovarian and Peritoneal Cancer. Gynecologic Oncology. 88(1). 51–57. 64 indexed citations
17.
Freed, Kelly S., et al.. (1999). MR imaging of an extrauterine lipoleiomyoma.. American Journal of Roentgenology. 172(4). 1144–1145. 3 indexed citations
18.
Tormey, William, et al.. (1999). Catecholamines in urine after death. Forensic Science International. 103(1). 67–71. 17 indexed citations
19.
Berchuck, Andrew & Michael E. Carney. (1997). Human ovarian cancer of the surface epithelium. Biochemical Pharmacology. 54(5). 541–544. 72 indexed citations
20.
Covens, Allan, Michael E. Carney, E. Franssen, et al.. (1995). Does Aggressive Therapy Improve Survival in Suboptimal Stage IIIc/IV Ovarian Cancer? A Canadian–American Comparative Study. Gynecologic Oncology. 59(2). 194–199. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026